SLC-0111, a ureido-substituted benzenesulfonamide, is a potent inhibitor of CA IX, disrupting pH regulation in tumor cells and impairing their survival and invasiveness (MedChemExpress, 2024). The gene discussed is CA9; the disease is neoplasm.